Abstract
Preformed amyloid fibrils can act as seeds for accelerating protein fibrillation. In the present study, we examined the effects of preformed seeds on lysozyme amyloid fibrillation in the presence of two distinct inhibitors–epigallocatechin (EGC) and polyethylene glycol 2000 (PEG). The results demonstrated that the effects of fibrillar seeds on the acceleration of lysozyme fibrillation depended on the aggregation pathway directed by an inhibitor. EGC inhibited lysozyme fibrillation and modified the peptide chains with quinone moieties in a concentration-dependent manner. The resulting aggregates showed amorphous off-pathway morphology. Preformed fibril seeds did not promote lysozyme fibrillation in the presence of EGC. PEG also inhibited lysozyme fibrillation, and the resulting aggregates showed on-pathway protofibrillar morphology. In contrast, the addition of fibril seeds into the mixture of lysozyme and PEG significantly stimulated fibril growth. Assays of cell viability showed that both EGC and PEG inhibited the formation of cytotoxic species. In accordance with thioflavine T data, the seeds failed to alter the cell-damaging potency of the EGC-directed off-pathway aggregates, but increased the cytotoxicity of the PEG-directed on-pathway fibrils. We suggest that the pattern of interaction between lysozyme and an inhibitor determines the pathway of aggregation and therefore the effects of seeding on amyloid formation. EGC covalently modified lysozyme chains with quinones, directing the aggregation to proceed through an off-pathway, whereas PEG affected the protein in a noncovalent manner, and fibril growth could be stimulated under seeding through an on-pathway.
Similar content being viewed by others
Abbreviations
- EGC:
-
epigallocatechin
- EGCG:
-
epigallocatechin-3-gallate
- MTT:
-
thiazolyl blue tetrazolium bromide
- NBT:
-
nitroblue tetrazolium
- PEG:
-
polyethylene glycol
- TEM:
-
trans-mission electron microscopy
- ThT:
-
thioflavine T
References
Stefani, M. (2004) Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world, Biochim. Biophys. Acta, 1739, 5–25.
Dobson, C. M. (2003) Protein folding and misfolding, Nature, 426, 884–890.
Nizhnikov, A. A., Antonets, K. S., and Inge-Vechtomov, S. G. (2015) Amyloids: from pathogenesis to function, Biochemistry (Moscow), 80, 1127–1144.
Bucciantini, M., Giannoni, E., Chiti, F., Baroni, F., Formigli, L., Zurdo, J., Taddei, N., Ramponi, G., Dobson, C. M., and Stefani, M. (2002) Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases, Nature, 416, 507–511.
Huang, B., He, J., Ren, J., Yan, X. Y., and Zeng, C. M. (2009) Cellular membrane disruption by amyloid fibrils involved intermolecular disulfide cross-linking, Biochemistry, 48, 5794–5800.
Hu, X., Crick, S. L., Bu, G., Frieden, C., Pappu, R. V., and Lee, J. M. (2009) Amyloid seeds formed by cellular uptake, concentration, and aggregation of the amyloid-beta peptide, Proc. Natl. Acad. Sci. USA, 106, 20324–20329. BIOCHEMISTRY (Moscow) Vol. 82 No. 2 2017
Furukawa, Y., Kaneko, K., Watanabe, S., Yamanaka, K., and Nukina, N. (2013) Intracellular seeded aggregation of mutant Cu,Zn-superoxide dismutase associated with amyotrophic lateral sclerosis, FEBS Lett., 587, 2500–2505.
Hall, D., Kardos, J., Edskes, H., Carver, J. A., and Goto, Y. (2015) A multi-pathway perspective on protein aggregation: implications for control of the rate and extent of amyloid formation, FEBS Lett., 589, 672–679.
Crespo, R., Villar-Alvarez, E., Taboada, P., Rocha, F. A., Damas, A. M., and Martins, P. M. (2016) What can the kinetics of amyloid fibril formation tell about off-pathway aggregation? J. Biol. Chem., 291, 2018–2032.
Ehrnhoefer, D. E., Bieschke, J., Boeddrich, A., Herbst, M., Masino, L., Lurz, R., Engemann, S., Pastore, A., and Wanker, E. E. (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers, Nature Struct. Mol. Biol., 15, 558–566.
Bieschke, J., Russ, J., Friedrich, R. P., Ehrnhoefer, D. E., Wobst, H., Neugebauer, K., and Wanker, E. E. (2010) EGCG remodels mature alpha-synuclein and amyloidbeta fibrils and reduces cellular toxicity, Proc. Natl. Acad. Sci. USA, 107, 7710–7715.
Williams, A. D., Sega, M., Chen, M., Kheterpal, I., Geva, M., Berthelier, V., Kaleta, D. T., Cook, K. D., and Wetzel, R. (2005) Structural properties of Aß protofibrils stabilized by a small molecule, Proc. Natl. Acad. Sci. USA, 102, 71157120.
Necula, M., Breydo, L., Milton, S., Kayed, R., Van der Veer, W. E., Tone, P., and Glabe, C. G. (2007) Methylene blue inhibits amyloid Abeta oligomerization by promoting fibrillization, Biochemistry, 46, 8850–8860.
Pepys, M. B., Hawkins, P. N., Booth, D. R., Vigushin, D. M., Tennent, G. A., Soutar, A. K., Totty, N., Nguyen, O., Blake, C. F., Terry, C. J., Feest, T. G., Zalin, A. M., and Hsuan, J. J. (1993) Human lysozyme gene mutations cause hereditary systemic amyloidosis, Nature, 362, 553–557.
Swaminathan, R., Ravi, V. K., Kumar, S., Kumar, M. V. S., and Chandra, N. (2011) Lysozyme: a model protein for amyloid research, Adv. Protein Chem. Struct. Biol., 84, 63–111.
Gharibyan, A. L., Zamotin, V., Yanamandra, K., Moskaleva, O. S., Margulis, B. A., Kostanyan, I. A., and Morozova-Roche, L. A. (2007) Lysozyme amyloid oligomers and fibrils induce cellular death via different apoptotic/necrotic pathways, J. Mol. Biol., 365, 1337–1349.
Frare, E., De Laureto, P. P., Zurdo, J., Dobson, C. M., and Fontana, A. (2004) A highly amyloidogenic region of hen lysozyme, J. Mol. Biol., 340, 1153–1165.
Munishkina, L. A., Cooper, E. M., Uversky, V. N., and Fink, A. L. (2004) The effect of macromolecular crowding on protein aggregation and amyloid fibril formation, J. Mol. Recognit., 17, 456–464.
Ghahghaei, A., Divsalar, A., and Faridi, N. (2010) The effects of molecular crowding on the amyloid fibril formation of a-lactalbumin and the chaperone action of acasein, Protein J., 29, 257–264.
Hatters, D. M., Minton, A. P., and Howlett, G. J. (2002) Macromolecular crowding accelerates amyloid formation by human apolipoprotein C-II, J. Biol. Chem., 277, 78247830.
Seeliger, J., Werkmuller, A., and Winter, R. (2013) Macromolecular crowding as a suppressor of human IAPP fibril formation and cytotoxicity, PLoS One, 8, e69652.
Sukenik, S., Politi, R., Ziserman, L., Danino, D., Friedler, A., and Harries, D. (2011) Crowding alone cannot account for cosolute effect on amyloid aggregation, PLoS One, 6, e15608.
Mittal, S., and Singh, L. R. (2014) Macromolecular crowding decelerates aggregation of a ß-rich protein, bovine carbonic anhydrase: a case study, J. Biochem., 156, 273–282.
Porat, Y., Abramowitz, A., and Gazit, E. (2006) Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism, Chem. Biol. Drug Des., 67, 27–37.
Feng, S., Song, X. H., and Zeng, C. M. (2012) Inhibition of amyloid fibrillation of lysozyme by phenolic compounds involves quinoprotein formation, FEBS Lett., 586, 39513955.
He, J., Xing, Y. F., Huang, B., Zhang, Y. Z., and Zeng, C. M. (2009) Tea catechins induced the conversion of preformed lysozyme amyloid fibrils to amorphous aggregates, J. Agr. Food Chem., 57, 11391–11396.
Kim, J., Lee, H. J., and Lee, K. W. (2010) Naturally occurring phytochemicals for the prevention of Alzheimer’s disease, J. Neurochem., 112, 1415–1430.
Shoval, H., Lichtenberg, D., and Gazit, E. (2007) The molecular mechanisms of the anti-amyloid effects of phenols, Amyloid, 14, 73–87.
Cao, N., Zhang, Y. J., Feng, S., and Zeng, C. M. (2015) Quinopeptide formation associated with the disruptive effect of epigallocatechin gallate on lysozyme fibrils, Int. J. Biol. Macromol., 78, 389–395.
Paz, M. A., Fluckiger, R., Boak, A., Kagan, H. M., and Gallop, P. M. (1991) Specific detection of quinoproteins by redox-cycling staining, J. Biol. Chem., 266, 689–692.
Mishra, R., Sorgjerd, K., Nystrom, S., Nordigarden, A., Yu, Y. C., and Hammarstrom, P. (2007) Lysozyme amyloidogenesis is accelerated by specific nicking and fragmentation but decelerated by intact protein binding and conversion, J. Mol. Biol., 366, 1029–1044.
Ghosh, S., Pandey, N. K., and Dasgupta, S. (2014) Crowded milieu prevents fibrillation of hen egg white lysozyme with retention of enzymatic activity, J. Photochem. Photobiol. B, 138, 8–16.
Ghosh, S., Pandey, N. K., and Dasgupta, S. (2013) Epicatechin gallate prevents alkali-salt mediated fibrillogenesis of hen egg white lysozyme, Int. J. Biol. Macromol., 54, 90–98.
Mossuto, M. F., Bolognesi, B., Guixer, B., Dhulesia, A., Agostini, F., Kumita, J. R., Tartaglia, G. G., Dumoulin, M., Dobson, C. M., and Salvatella, X. (2011) Disulfide bonds reduce the toxicity of the amyloid fibrils formed by an extracellular protein, Angew. Chem. Int. Ed., 50, 70487051.
Hill, S. E., Miti, T., Richmond, T., and Muschol, M. (2011) Spatial extent of charge repulsion regulates assembly pathways for lysozyme amyloid fibrils, PLoS One, 6, e18171.
Wawer, J., Krakowiak, J., Szocinski, M., Lustig, Z., Olszewski, M., and Szostak, K. (2014) Inhibition of amyloid fibril formation of hen egg white lysozyme by trimethylamine N-oxide at low pH, Int. J. Biol. Macromol., 70, 214221.
Harada, A., Azakami, H., and Kato, A. (2008) Amyloid fibril formation of hen lysozyme depends on the instability of the C-helix (88-99), Biosci. Biotechnol. Biochem., 72, 1523–1530.
Kumar, S. V., Ravi, K., and Swaminathan, R. (2008) How do surfactants and DTT affect the size, dynamics, activity and growth of soluble lysozyme aggregates? Biochem. J., 415, 275–288.
Ravi, V. K., Swain, T., Chandra, N., and Swaminathan, R. (2014) On the characterization of intermediates in the isodesmic aggregation pathway of hen lysozyme at alkaline pH, PLoS One, 9, e87256.
Serio, T. R., Cashikar, A. G., Kowal, A. S., Sawicki, G. J., Moslehi, J. J., Serpell, L., Arnsdorf, M. F., and Lindquist, S. L. (2000) Nucleated conformational conversion and the replication of conformational information by a prion determinant, Science, 289, 1317–1321.
Esler, W. P., Stimson, E. R., Jennings, J. M., Vinters, H. V., Ghilardi, J. R., Lee, J. P., Mantyh, P. W., and Maggio, J. E. (2000) Alzheimer’s disease amyloid propagation by a template-dependent dock-lock mechanism, Biochemistry, 39, 6288–6295.
Nguyen, P. H., Li, M. S., Stock, G., Straub, J. E., and Thirumalai, D. (2007) Monomer adds to preformed structured oligomers of Aß-peptides by a two-stage dock-lock mechanism, Proc. Natl. Acad. Sci. USA, 104, 111–116.
Grigorashvili, E. I., Selivanova, O. M., Dovidchenko, N. V., Dzhus, U. F., Mikhailina, A. O., Suvorina, M. Y., Marchenkov, V. V., Surin, A. K., and Galzitskaya, O. V. (2016) Determination of size of folding nuclei of fibrils formed from recombinant Aß(1-40) peptide, Biochemistry (Moscow), 81, 538–547.
Selivanova, O. M., Glyakina, A. V., Gorbunova, E. Y., Mustaeva, L. G., Suvorina, M. Y., Grigorashvili, E. I., Nikulin, A. D., Dovidchenko, N. V., Rekstina, V. V., Kalebina, T. S., Surin, A. K., and Galzitskaya, O. V. (2016) Structural model of amyloid fibrils for amyloidogenic peptide from Bgl2p-glucantransferase of S. cerevisiae cell wall and its modifying analog. New morphology of amyloid fibrils, Biochim. Biophys. Acta, 1864, 1489–1499.
Wenner, J. R., and Bloomfield, V. A. (1999) Crowding effects on EcoRV kinetics and binding, Biophys. J., 77, 3234–3241.
Hirata, Y., Sano, Y., Aoki, M., Shohji, H., Katoh, S., Abe, J., Hitsukuri, S., and Yamamoto, H. (2003) Small-angle Xray scattering studies of moderately concentrated dextran solution, Carbohydr. Polym., 53, 331–335.
Breydo, L., Reddy, K. D., Piai, A., Felli, I. C., Pierattelli, R., and Uversky, V. N. (2014) The crowd you’re in with: effects of different types of crowding agents on protein aggregation, Biochim. Biophys. Acta, 1844, 346–357.
Phillip, Y., and Schreiber, G. (2013) Formation of protein complexes in crowded environments -from in vitro to in vivo, FEBS Lett., 587, 1046–1052.
Gaharwar, B., Gour, S., Kaushik, V., Gupta, N., Kumar, V., Hause, G., and Yadav, J. K. (2015) Assessment of the effect of macromolecular crowding on aggregation behavior of a model amyloidogenic peptide, Protein Pept. Lett., 22, 87–93.
Necula, M., Kayed, R., Milton, S., and Glabe, C. (2007) Small molecule inhibitors of aggregation indicate that amyloid-ß oligomerization and fibrillization pathways are independent and distinct, J. Biol. Chem., 282, 10311–10324.
Moores, B., Drolle, E., Attwood, S. J., Simons, J., and Leonenko, Z. (2011) Effect of surfaces on amyloid fibril formation, PLoS One, 6, e25954.
Pellarin, R., Schuetz, P., Guarnera, E., and Caflisch, A. (2010) Amyloid fibril polymorphism is under kinetic control, J. Am. Chem. Soc., 132, 14960–14970.
Author information
Authors and Affiliations
Corresponding author
Additional information
Published in Russian in Biokhimiya, 2017, Vol. 82, No. 2, pp. 266-279.
Originally published in Biochemistry (Moscow) On-Line Papers in Press, as Manuscript BM16-252, November 7, 2016.
Rights and permissions
About this article
Cite this article
Kong, LX., Zeng, CM. Effects of seeding on lysozyme amyloid fibrillation in the presence of epigallocatechin and polyethylene glycol. Biochemistry Moscow 82, 156–167 (2017). https://doi.org/10.1134/S0006297917020079
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S0006297917020079